Thanks barracudaking for the article, very informative and gives me even more believe in what we have.
Eire 2011, Thankyou also for your informative posts.
Do you know how long it we take to evaluate the effectiveness of these first human trials?
Also has anybody mentioned the number of people who will be taking part in receiving these new valves?
Lastly, any idea of the cost with taking the trials from here to completion, all going according to plan?
Thanks to anyone who maybe able to help.
Regards
Dabru
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-10
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |